Active Specific Immunotherapy in the Management of Adenocarcinoma of the Pancreas

Autor: BR Yacyshyn, BM Longenecker, WA Biermann, D McClure, S Poppema, MB Bowen-Yacyshyn

Publikováno v: Canadian Journal of Gastroenterology, Vol 9, Iss 4, Pp 213-216 (1995)

Active specific immunotherapy for pancreatic adenocarcinoma and subsequent immunohistochemical analysis of tumour tissue have not been previously reported. To date, the therapy of pancreatic adenocarcinoma has been largely unsuccessful. A patient tre

Externí odkaz: https://doaj.org/article/66a9f868908f4a94932565fcf99c4f86

Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells

Autor: PJ Simmons, B Masinovsky, BM Longenecker, R Berenson, B Torok-Storb, WM Gallatin

Publikováno v: Blood. 80:388-395

Human bone marrow-derived CD34+ cells were analyzed for the expression of the beta 1-family of integrin adhesion molecules. Integrin alpha 4 beta 1 was consistently expressed by greater than 90% of CD34+ cells, including essentially all assayable gra

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5e5235e55ea5e22902d23634a860b68c
https://doi.org/10.1182/blood.v80.2.388.bloodjournal802388

Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigen

Autor: Bm Longenecker, Mb Bowenyacyshyn, J Nation, M Jerry, Gavin Stuart, R Koganty, Sibrand Poppema, A Meikle, John Samuel, Gd Maclean, Ting Chi Wong

Publikováno v: Journal of immunotherapy : official journal of the Society for Biological Therapy. 11(4)

In a phase I study, ten ovarian cancer patients with extensive metastatic disease despite chemotherapy were immunized three to eight times subcutaneously with the synthetic form of the immunodominant disaccharide (beta Gal1----3 alpha GalNAc) of the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc81861320d7b6c5f1003d9f99a910c9
https://pubmed.ncbi.nlm.nih.gov/1599915

MUC1 mucin-mediated regulation of human T cells.

Autor: Agrawal B; 611-Heritage Medical Research Centre, Department of Surgery, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, T6G 2S2, Canada. bagrawal@ualberta.ca, Longenecker BM

Publikováno v: International immunology [Int Immunol] 2005 Apr; Vol. 17 (4), pp. 391-9. Date of Electronic Publication: 2005 Feb 14.

Mucin 1-specific immunotherapy in a mouse model of spontaneous breast cancer.

Autor: Mukherjee P; Department of Biochemistry and Molecular Biology, Mayo Clinic Scottsdale, Scottsdale, Arizona 85259, U.S.A., Madsen CS, Ginardi AR, Tinder TL, Jacobs F, Parker J, Agrawal B, Longenecker BM, Gendler SJ

Publikováno v: Journal of immunotherapy (Hagerstown, Md. : 1997) [J Immunother] 2003 Jan-Feb; Vol. 26 (1), pp. 47-62.